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AntifolatesPlasmodial bifunctional dihydrofolate reductase-thymidylate synthase (DHFR-TS) is a validated antimalarial
drug target. In this study, expression of the putative dhfr-ts of Plasmodium ovale rescued the DHFR chemical
knockout and a TS null bacterial strain, demonstrating its DHFR and TS catalytic functions. PoDHFR-TS was
expressed in Escherichia coli BL21 (DE3) and afﬁnity puriﬁed byMethotrexate Sepharose column. Biochemical
and enzyme kinetics characterizations indicated that PoDHFR-TS is similar to other plasmodial enzymes, albeit
with lower catalytic activity but better tolerance of acidic pH. Importantly, the PoDHFR from Thai isolate
EU266602 remains sensitive to the antimalarials pyrimethamine and cycloguanil, in contrast to P. falciparum
and P. vivax isolates where resistance to these drugs is widespread.
© 2011 Elsevier Ireland Ltd. Open access under CC BY license.1. Introduction
Malaria is caused by Plasmodium protozoan transmitted by female
Anopheles mosquitoes. There are ﬁve species that infect human,
namely, P. falciparum (Pf), P. vivax (Pv), P. malariae (Pm), P. ovale
(Po), and P. knowlesi (Pk). P. falciparum and P. vivax are the most
prevalent species found in most endemic areas, whereas P. malariae
and P. ovale infections have patchy and limited distribution [1–3].
P. knowlesi is a zoonosis parasite recently reported to be the ﬁfth
human-infecting malaria species [4]. Mixed infections by these parasite
species also are generally observed [5].midylate synthase; JR, junction
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panich).
r CC BY license.Parasite detection by blood smears observed under a light micro-
scope is the most common tool used in the ﬁeld in order to assess
the levels of clinical infection and for epidemiological surveillances.
However, differentiation of Plasmodium species, especially of P. ovale,
P. malariae, and P. knowlesi by light microscopy can be challenging
[6]. Indeed, the detection limit of light microscopy has been suggested
to be a cause of low incidences reported for malaria cases caused
by these species [7]. In addition, information on drug resistance is
important in designing strategic plans to control the spread of malaria
infection and providing effective treatment for the patients. These
data are well established for P. falciparum and P. vivax, but they have
been overlooked for the others. It is well established that a drug
deployment policy for one particular malaria parasite species can
lead to selection pressure on other Plasmodium species, as exempliﬁed
by the spillover of antifolate resistant phenotype observed in
P. falciparum into P. vivax [8–10].
Unlike P. falciparum, where continuous in vitro culture has been
routinely established [11], cultures of the other malaria parasite
species, including P. ovale, have yet to be established. Therefore,
determination of in vitro drug susceptibility in these parasites
cannot be made. However, the putative gene of P. ovale dihydrofo-
late reductase-thymidylate synthase (PoDHFR-TS), a known antifo-
late target, has recently been identiﬁed and sequenced [12]. Here,
we report the cloning and heterologous expression of PoDHFR-TS
gene from a Thai isolate (EU266602), together with protein
Table 1
Oligonucleotides used to perform site-directed mutagenesis to correct the sequence of
cloned podhfr-ts.
Corrected
mutation
Sense (F) and antisense (R) primers used
I225T F; GTAGTAACGGAACCACATTAGACTTTCTAATTTA
R; TAAATTAGAAAGTCTAATGTGGTTCCGTTACTAC
236K F; TTACAGTAGGAAAAAAAAAGACACACAAAATG
R; CATTTTGTGTGTCTTTTTTTTTCCTACTGTAA
S258T F; GCTACAGCTACAGCGACATGGCCAGGAATAG
R; CTATTCCTGGCCATGTCGCTGTAGCTGTAGC
R303W F; GGAGCAGAATGGTGGGGAAATATGGCT
R; AGCCATATTTCCCCACCATTCTGCTCC
H476Y, D478N F; GCTGAATATACAAATATGTATGATAATTATGAAAATAAAGGAATTG
R; CAATTCCTTTATTTTCATAATTATCATACATATTTGTATATTCAGC
Corrected nucleotides are underlined.
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ization were performed to verify the coding sequence as DHFR-TS.
The sensitivity to antifolate antimalaria of the expressed PoDHFR-
TS was assessed.
2. Materials and methods
2.1. Molecular cloning of P. ovale dihydrofolate reductase-thymidylate
synthase (podhfr-ts) gene
The genomic DNA was prepared from a Thai isolate (EU266602),
for which the P. ovale infection was conﬁrmed using 2 PCR protocols
based on the ampliﬁcation of species speciﬁc small subunit rRNA
(SSU rRNA) and linker region (or junction region; jr) of the dhfr-ts
genes [13,14]. Full-length podhfr-ts (1920 bp) was generated by an
overlap extension PCR technique [15]. The dhfr-jr and jr-ts DNA
fragments were separately ampliﬁed and each fragment contained a
54 bp overlapping ﬂanking sequence in order to mediate homologous
recombination that generated the full-length podhfr-ts as described
below. Unless otherwise indicated, PCR reactions were carried out
in a total volume of 50 μL containing 100 ng of DNA template,
125 μM dNTPs, 250 nM each of sense and antisense primers, and 3 U
of Pfu polymerase (Promega Corporation, WI, USA).
The sequence coding for podhfr-jr was ampliﬁed from pGemT-
podhfr plasmid using primers 5′PoDHFR (ATGGAGGAAGTCTCA-
GAGGTTTTC) and 3′Po-link (GATGATCCTTTTCCGTGATGAGAAG). PCR
thermocycling conditions were as follows: 95 °C for 5 min; 30 cycles
of 94 °C for 1 min, 50 °C for 1 min and 72 °C for 2 min; and a ﬁnal
heating at 72 °C for 5 min. The amplicon (863 bp) was puriﬁed
using GeneJET™ Plasmid Miniprep Kit (Fermentas, Burlington,
Canada).
The pojr-ts fragment was ampliﬁed directly from P. ovale genomic
DNA using primers 5′Po-link (GCAGGAGCTACCTCTTCCATG) and 3′
PoTS (TTAGGCGGCCATATCCATAGTGAT). Taq DNA polymerase was
used in the PCR with the following thermocycling conditions:
1 cycle of 95 °C for 5 min; 30 cycles of 94 °C 1 min, 55 °C 1 min and
72 °C 1 min; and a ﬁnal cycle of 72 °C 5 min. The expected jr-ts ampli-
con (1134 bp) was puriﬁed from 0.8% agarose using GeneJET™ Gel
Extraction Kit (Fermentas, Burlington, Canada). The extracted pojr-ts
was ligated into T-overhang pTZ57R/T plasmid (Fermentas, Burlington,
Canada) and the resulting pTZ57R/T-pojr-ts plasmid construct was used
as a template to re-amplify pojr-ts sequence using conditions as
described above, except that Pfu polymerase and an elongation time
of 2.5 min were used.
In order to obtain the full-length podhfr-ts, 50 ng each of the podhfr-
jr and pojr-ts fragments were combined and PCR was performed with-
out addition of primers using the following thermocycling conditions:
1 cycle of 95 °C for 5 min; 30 cycles of 94 °C for 1 min, 70 °C for 1 min
and 72 °C for 2.5 min; and a ﬁnal step at 72 °C for 5 min. Then 1.0 μL
of the PCR solution together with primers 5′NhePo (CACCGCTAGCATG-
GAGGAAGTCTCAGAGGT; Nhe I restriction site as underlined) and 3′
PoTS were used in the subsequent PCR with the following thermocy-
cling conditions: 1 cycle of 95 °C for 5 min; 30 cycles of 94 °C for
1 min, 60 °C for 1 min, and 72 °C for 4 min; and a ﬁnal step at
72 °C for 5 min.
The podhfr-ts was digested with Nhe I and ligated into pET17b
(Invitrogen) vector, which had previously been digested with Nhe I
and EcoR V. The insert sequence was analyzed by 1st BASE (Selangor
Darul Ehsan, Malaysia) and Genome Institute (Pathumthani,
Thailand).
Site-directed mutagenesis experiments were performed to correct
any mutations occurring. The reaction contained 50 ng template,
125 μM dNTPs, 250 nM sense and antisense primers, and 3 U of
Pfu polymerase. Similar PCR conditions as described above were
employed, except that the condition for annealing and elongation
was 61 °C for 1 min and 72 °C for 11 min respectively. Sense andantisense primers used to correct the mutations are listed in Table 1,
which shows the corrected nucleotides (underlined).
2.2. Complementation assay
For DHFR activity test, E. coli BL21 (DE3) was transformed with
pET17bPoDHFR-TS and plated on LB agar containing 100 μg/ml
ampicillin. A single colony of transformed cell was cultured in 5 mL of
LB broth supplemented with 100 μg/ml ampicillin at 37 °C until OD600
reached 0.8. Cells (5 μL) were spotted on minimum media (MM) agar
plate supplemented with 100 μg/ml ampicillin in either the presence
or absence of 4 μM trimethoprim (TMP), and incubated at 37 °C over-
night. Cells transformed with pET17b were used as a negative control.
For TS activity test, a Thy¯ E. coli strain χ 2913recA-DE3 (Δ thyA572,
recA56) [16] was used. Similar experiment to that described for DHFR
activity test was performed, except that MM agar plate contained
100 μg/ml ampicillin in the presence or absence of 50 μg/ml thymidine.
2.3. PoDHFR-TS enzyme expression and puriﬁcation
E. coli BL21 (DE3) harboring pET17bPoDHFR-TS plasmidwas used for
expression of PoDHFR-TS. Cells were grown in SOBmedium supplemen-
ted with 100 μg/ml ampicillin at 37 °C until OD600 reached 1.0, when ex-
pression of PoDHFR-TS was induced by supplementation with 0.4 mM
IPTG. Cells were grown at 16 °C for 20 h, collected by centrifugation at
10,000 g for 10 min and lysed using a French press (Thermo Dynamics
Ltd., Nova Scotia, Canada) at 69 MPa in buffer A (20 mMpotassiumphos-
phate pH 7.0, 50 mMKCl, 0.1 mMEDTA, 10 mMDTT, and 20% (v/v) glyc-
erol). Cell lysate was centrifuged at 27,000 g for 1 h, and PoDHFR-TS in
the supernatantwas puriﬁedusingMTX-afﬁnity chromatography as pre-
viously described [17]. Brieﬂy, the supernatant was loaded onto MTX-
Sepharose pre-equilibrated with buffer A and the nonspeciﬁc binding
proteins were washed by buffer A containing 1 M KCl. PoDHFR-TS was
eluted by buffer B (50 mM TES pH 8.0, 0.1 mM EDTA, 10 mM DTT,
50 mM KCl, 20% (v/v) glycerol, and 4 mM H2folate).
Fractions containing DHFR activity was further puriﬁed by passage
over a Sephacryl S-200 HR column (2.5×90 cm), using buffer A at a
ﬂow rate of 0.2 mL/min. Another approach used for PoDHFR-TS puri-
ﬁcation was Q-Sepharose anion-exchange chromatography (3×5 cm
column) using a linear salt gradient from 0.05 to 1 M NaCl in buffer A
(100 mL total volume). SDS-PAGE was used to demonstrate protein
expression and purity.
2.4. PoDHFR-TS enzyme identiﬁcation
Protein bands observed on Coomassie blue-stained SDS-PAGE were
subjected to an in-gel tryptic digestion, and identiﬁed by LC-MS/MS
(Genome Institute, Pathumthani, Thailand). All MS/MS spectra were
searched against database using SEQUEST algorithm by ﬁltering of
cross-correlation score (Xcorr) versus charge state (+1≥1.5,+2≥2.0,
Table 2
Sequence analysis of DHFR domain among ﬁve Plasmodium species as well as the variant and classic dimorphic types of P. ovale from different regions. Accession numbers J03028, EU478859, AY846633, and XM002258192 belong to PfDHFR-
TS (Pf), PvDHFR-TS (Pv), PmDHFR-TS (Pm), and PkDHFR-TS (Pk). Amino acid positions in PfDHFR-TS (16, 51, 59, 108, and 164) and PvDHFR-TS (57, 58, 61, 117, and 173) implicated in antifolate resistance are bolded. The symbol (.)
represents the same amino acid as that presence in P. ovale strain EU 266602 (bolded letter). ND = no data available.
Accession no. Origin Amino acid number in DHFR domain
J03028 (Pf) FCR3, Lab strain 4 5 6 7 14 16 32 34 40 50 51 57 58 59 62 71 91 108 113 159 161 164 173 179 182 199 202 204 207
Q V C D I A/V F N L C N/I Y F C/R T E D S/N,T P Y C C I/L F I I E E E I
EU478859 (Pv) India 3 4 5 6 13 15 31 33 39 49 50 56 57 58 61 70 100 117 122 168 170 173 182 188 191 208 211 213 216
D L S D I/L A F P L C N Y F/L S/R T/M E G S P Y C I C I I E E Q V
AY846633 (Pm) Thailand 3 4 5 6 13 15 31 33 39 49 50 56 57 58 61 70 97 114 119 165 167 170 179 185 188 205 208 210 213
E V S D I A F T L S N Y F S T K S S P Y C I C I I E E V I
XM002258192 (Pk) Malaysia 3 4 5 6 13 15 31 33 39 49 50 56 57 58 61 70 100 117 122 168 170 173 182 188 191 208 208 213 216
D L S E I A F P L C N Y F S T E T S P Y C I C I I Q E Q M
Type 3 4 5 6 13 15 31 33 39 49 50 56 57 58 61 70 96 113 118 164 166 169 178 184 187 204 207 209 212
EU266602 Thailand Variant E V S E I A F S I C N Y F S T K I S P Y C I C I I D E A I
GQ250091 PNG Variant Q L . D . . . . . . . . . . . . . . . . . . . . . . . . .
EU266604 Benin Variant Q L . D . . . . . . . . . . . . . . . . . . . . . M . . .
EU266605 Sao Tome Variant Q L . D . . . . V . . C . . . . . . . . . . . . . . . . .
EU266612 Thailand Variant ND ND ND ND . . . . . . . . . . . . . . . . . . . . . . . . .
EU266613 Thailand Variant ND ND ND ND . . . . . . . . . . . . . . . H . . . . . . . . .
EU266614 Thailand Variant ND ND ND ND . . . . . . . . . . . . . . . . . . . . . . . . .
EU266615 Thailand Variant ND ND ND ND . . . . . . . . . . . . . . . . . . . . . . .
EU266616 Thailand Variant ND ND ND ND . . . . . . . . . . . . . . . . . . Y . . . . . .
EU266617 Thailand Variant ND ND ND ND . . . . . . . . . . . . . . . . . . . . . . . T .
EU266618 Thailand Variant ND ND ND ND . . . . . . . . . . . . . . . . . . . . . . . . .
GQ250090 Variant . L C . . . . . . . . . . . . . . . . . . . . . . . . . .
EU266606 Sao Tome Classic H . C D . . Y N . Y . . . . . N . . . . . . . . V E K T .
EU266607 Sao Tome Classic ND ND ND ND . . Y N . Y . . . . . N . . L . . . . . V E K T .
EU266608 Guinea-Bissau Classic ND ND ND ND . . Y N . Y . . . . . N . . . . . . . . V E K T .
EU266609 Guinea-Bissau Classic ND ND ND ND . . Y N Y . . . . . D M . . . . . . . V E K T .
EU266610 Guinea-Bissau Classic ND ND ND ND . . Y N . Y . . . . . N . . . . R . . . V G K T .
EU266611 Guinea-Bissau Classic ND ND ND ND . . Y N . Y . . . . . N . . . . . . . . V E K T V
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BFig. 1. Sequence analyses. (A) Multiple amino acid sequence alignment of PoDHFR-TS variant (EU266602), PoDHFR-TS classic (EU266606), PfDHFR-TS (J03028), PvDHFR-TS
(EU478859), PmDHFR-TS (AY846633), and PkDHFR-TS (XM002258192). Numbers in brackets indicate percent homology to PoDHFR-TS variant EU266602. Amino acids A16,
N51, C59, S108, and I164 in PfDHFR-TS and F57, S58, T61, S117, I173 in PvDHFR-TS are highlighted in bold. Mutations at these positions have been reported to be associated
with antifolate resistance. Residues known to be important for TS activity are shown as underlined bold letters. T225, T258, W303, Y476, and N478 — for which the errors were
found in the encoded nucleotides during the cloning process — are denoted in italic with bold letters. (*) amino acid positions with identical residue, (:) amino acid positions
with conserved substitution amino acid, (.) amino acid positions with semi-conserved substitution amino acid, and (non-marked) amino acid positions with non-conserved sub-
stitution amino acid. (B) The results by LC-MS/MS of tryptic digested fragments of 74 (solid line), 35 (dotted line), and 32 (dash line) kDa proteins matched to DHFR-TS of P. ovale.
Highlighted amino acids are N-terminal sequences obtained by Edman N-terminal sequencing of 74, 35, and 32 kDa proteins. Asterisk (*) and hash (#) symbols represent sequences
of 35 and 32 kDa protein respectively, identiﬁed by Edman N-terminal sequencing. The ﬁrst three amino acids (bold letters) are extra residues generated from cloning of podhfr-ts
into Nhe I site of pET17b.
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(Primary Score) of greater than 500.
For N-terminal sequence analysis, protein bands on SDS-PAGE
were transferred onto PVDF membrane (Millipore, Massachusetts,
USA) and subsequently sequenced by Edman degradation method
(AltaBioscience, Birmingham, UK).
2.5. Kinetic characterization of DHFR and TS activities
DHFR enzyme activity was measured spectrophotometrically at
340 nm for the decrease of NADPH substrate and the activity was
calculated using a molar absorptivity (ε340) of 12,300 M−1 cm−1 [18].
One unit of DHFR activity is deﬁned as the amount of the enzyme
that catalyzes the reduction of 1 μmol of substrate per minute at 25 °C.
The assay solution (1 mL) contained 50 mM TES pH 7.0, 75 mM β-
mercaptoethanol, 1 mM EDTA, 100 μM H2folate, 100 μM NADPH,
1 mg/ml BSA and enzyme. Km values for H2folate and NADPHwere con-
ducted at a range of 1–100 μM for one substrate while keeping ﬁxed the
concentration of the other at 100 μM. All reactions were initiated with0.005 enzyme unit and performed in a Hewlett Packard UV–VIS spec-
trophotometer (HP8453). Data were ﬁtted to a Michaelis–Menten
equation using a non-linear least-square ﬁtting module of Kaleida-
Graph™ software (Synergy Software, Pennsylvania, USA).
TS enzyme activity was measured spectrophotometrically by
monitoring at 25 °C the increase in absorbance at 340 nm due to
the formation of H2folate, performed with an approximately
0.006 enzyme unit in TS buffer (50 mM TES pH 7.4, 25 mM MgCl2,
6.5 mM HCOH, 1 mM EDTA and 75 mM β-mercaptoethanol),
150 μM of (6R)-CH2H4folate (Merck Eprova AG, Switzerland), and
125 μM dUMP (to initiate reaction). Enzyme activity was calculated
using a molar extinction coefﬁcient (ε340) of 6,400 M−1 cm−1 [19].
One unit of TS activity is deﬁned as the amount of the enzyme that
catalyzes the formation of 1 μmol of product per minute. Km values
for (6R)-CH2H4folate and dUMP were performed using a saturation
concentration of one substrate (150 μM for (6R)-CH2H4folate and
125 μM for dUMP) and varying the concentration of the other
(2–150 μM for (6R)-CH2H4folate and 1–125 μM for dUMP), and
data were analyzed as described for DHFR.
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TS labeling by 6-[3H] FdUMP was performed as previously
described [20–22]. In brief, 2 μg of puriﬁed PoDHFR-TSwere incubated
with 5 μL of 3 mM (6R)-CH2H4folate, 0.25 μL of 66 μM 6-[3H] FdUMP
(15 Ci/mmol, Moravek Biochemicals, California, USA) in TS buffer
(20 μL ﬁnal volume) at 25 °C for 1 h. The reaction was stopped by
adding SDS dye solution and boiling for 10 min. The protein complex
was analyzed by 12.5% SDS-PAGE. The Coomassie-blue dye stained gel
was soaked in autoradiography enhancer (NEN™, Dupont) for 1 h at
25 °C with gently shaking, dried at 80 °C, and exposed to Hyperﬁlm
(Amersham Hyperﬁlm ECL™, GE Healthcare Life Science) at −80 °C
for one day. The procedure was performed with Trypanosoma cruzi
DHFR-TS as positive control and with PvDHFR as a negative control.
2.7. Effect of pH on reaction catalysis
The pH dependences for DHFR and TS activities were monitored as
described in Section 2.5 but using polybuffer in the pH range of 4–9.5
at 25 °C. For assay of DHFR activity the polybuffer was composed of
50 mM acetic acid, 50 mM MES, 100 mM Tris-Cl, and 10 mM β-
mercaptoethanol, and for TS activity the polybuffer buffer was
supplemented with 25 mM MgCl2, 6.5 mM HCOH, and 1 mM EDTA.
Catalytic constant was plotted as a function of pH.
2.8. Inhibition of DHFR by antifolates
Inhibition of DHFR activity by antifolate compounds [pyrimethamine
(PYR) and cycloguanil (CYC)] were determined in 1 mL of DHFR assay
solution containing 100 μM NADPH and H2folate, together with 5 nM–
1 μM inhibitors. Reaction was initiated by adding 0.01 enzyme unit.
Inhibition constant (Ki) was calculated from a non-linear least-square
ﬁt of data using KaleidaGraph™ software. The type of inhibition by anti-
folate compounds was analyzed using DHFR assay solution containing
100 μMNADPHwith varying (2.5 μM–12.5 μM)H2folate concentrations.
Data were analyzed using a Lineweaver–Burk plot of the reciprocal
values of initial velocity and concentrations of H2folate.
3. Results and discussion
3.1. Analysis of PoDHFR-TS sequence
A recent study by multi-locus sequence analysis identiﬁed 2 non-
recombining sympatric forms of P. ovale, classic and variant types, or
P. ovale curtisi and P. ovale wallikeri respectively [12]. At present, 18
podhfr-ts sequences derived from ﬁeld isolates of different geographic
regions have been reported [12]. Sequence comparisons reveal
dimorphic patterns in PoDHFR-TS (Table 2), and the variant type
contains 2 amino acids more than that of the classic type (639 versus
637 residues) in the junction region (Fig. 1A). P. ovale variant type is
mostly observed for Thai isolates (8 out of 12), while the classic type
is from Sao Tome (2 out of 6) and Guinea-Bissau (4 out of 6)
(Table 2). It is noted that none of the parasites from Thai isolates
belong to the classic type. Examples of dimorphic patterns observed
in DHFR domain are demonstrated — F/Y31, S/N33, C/Y49, I/V187,
D/E204, E/K207, and A/T209 (Table 2). These polymorphisms are
not equivalent to those associated with antifolate resistance in
PfDHFR-TS and PvDHFR-TS. Thus, it is unlikely that the PoDHFR-TS
enzyme would be resistant to antifolates, unless these polymorphisms
signiﬁcantly affect the binding characteristics of the active site. Point
mutations in Plasmodium DHFR responsible for antifolate resistance
have been well characterized for P. falciparum (A16V, N51I, C59R,
S108N, and I164L) and P. vivax (F57L, S58R, T61M, S117N, and
I173L) [23,24]. These residues in variant and classic PoDHFRs are
identical— A15, N50, F57, S58, T61, S113, and I169—which are similar
to the wild-type sequence of other Plasmodium DHFRs (Table 2). Theconserved R470 and C490 in PfDHFR-TS are important for TS activity
[16], for which these residues are equivalent to R501 and C521 of
PoDHFR-TS variant or R499 and C519 for the classic type (Fig. 1A).
Using P. ovale strain EU266602, a variant type, as the reference
sequence, a number of sequence variations were identiﬁed among
different isolates such as E3Q/H, V4L, E6D, I39V, Y56C, I96M, Y164H ,
C166R, C178Y, I184M, and I212V. These variations were conﬁrmed
as the sequences of each isolate were derived from at least 2 colonies
after cloning.
3.2. Construction of podhfr-ts expression vector
Initial attempts to PCR amplify the open reading frame (ORF) of
podhfr-ts from genomic DNA resulted in the production of partial
gene sequences. Eventually, the full-length podhfr-ts was successfully
ampliﬁed using an overlap extension PCR-based method (Fig. S). In
this approach, podhfr and pots with ﬂanking homologous sequence
were synthesized ﬁrst (Fig. S; PCR 2), and the amplicons were then
used as templates and primers for sequence extension in the following
PCR (Fig. S; PCR 3). Another PCR was required in order to obtain sufﬁ-
cient amounts of DNA for further cloning step (Fig. S; PCR 4). A major
amplicon of 1920 bp was ﬁnally obtained (Fig. S; PCR 4). Reasons for
the unsuccessful ampliﬁcation of the full-length gene by direct PCR am-
pliﬁcation fromgenomic DNA include primers annealing at non specif-
ic sites, and presence of DNA secondary structures due to the high
AT content (67%) thereby hindering polymerase processivity.
Upon ligation at Nhe I and EcoR V sites, 3 amino acids, namely,
methionine, alanine, and serine, are introduced upstream of the
initiation methionine of PoDHFR-TS. Five missense mutations (T225I,
ACA→ATA; T258S, ACA→TCA;W303R, TGG→AGG;Y476H, TAT→CAT;
and N478D, AAT→GAT) and one missing nucleotide (A708) of K236
were found from the ﬁrst expression construct generated. Amino acids
T225, T258, W303, Y476, and N478 are conserved in all 18 isolates, in
which the sequences were reported [12]. The errors observed were likely
to be due to the use of multiple steps of PCR and of Taq DNA polymerase,
a non proofreading DNA polymerase [25]. The sequence was corrected
by site-directed mutagenesis and the ﬁnal expression construct,
pET17bPoDHFR-TS, encodes 642 amino acids, which share 65–75,
19–32, and 90% identities for the DHFR, JR, and TS domains, respectively,
with other human plasmodial species (Fig. 1A).
3.3. Complementation assay
Bacterial complementation assays were carried out to provide
preliminary evidence for DHFR and TS functions of the heterologously
expressed protein. DHFR activity was investigated through its ability
to complement bacterial cell activity in the presence of TMP, a speciﬁc
bacterial DHFR inhibitor. E. coli transfected with pET17bPoDHFR-TS
could grow on MM plate containing 4 μM TMP, whereas cells carrying
an empty plasmid was suppressed (Fig. 2A). A similar strategy was
employed for TS activity determination, using Thy¯ E. coli strain χ
2913recA-DE3. Such cells carrying pET17bPoDHFR-TS were able to
grow in the absence of thymidine supplementation, as was required
by untransfected control cells (Fig. 2B).
Since at present it is not possible to maintain P. ovale in continuous
culture, this bacterial complementation assay provides a useful
means to evaluate novel compounds with potential inhibitory
properties directed against P. ovale DHFR and TS, as well as evaluating
mutant enzymes from ﬁeld isolates and constructed in the laboratory.
A similar approach was recently used for screening antifolates for
PvDHFR [26].
3.4. Enzyme expression and puriﬁcation
Heterologous expression of recombinant PoDHFR-TS in E. coli
BL21 (DE3) induced with 0.4 mM IPTG at 16 °C for 20 h was
Fig. 2. Bacterial complementation assays to demonstrate DHFR and TS functions of
PoDHFR-TS coded sequence. (A) E. coli BL21 (DE3) transformed with either pET17b
or pET17bPoDHFR-TS was grown on MM in the absence or presence of 4 μM TMP.
(B) E. coli χ 2913recA-DE3 carrying pET17b or pET17bPoDHFR-TS was cultured on
MM with and without 50 μg/ml thymidine. MM used in A and B also contained
100 μg/ml ampicillin.
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tempts to increase yield by varying host cell types and IPTG con-
centrations were unsuccessful (data not shown). The expressed
PoDHFR-TS protein was puriﬁed using MTX-afﬁnity chromatogra-
phy, yielding 12 mg of enzyme, with a speciﬁc activity of 1.7μmol/
min/mg, from 1 L culture. Upon the analysis by SDS-PAGE, in addi-
tion to the expected protein band of 74 kDa, proteins of 35 and
32 kDa also were observed, accounting for 50% of the total protein
in the gel (Fig. 3). Further puriﬁcation by gel ﬁltration and anion-
exchange chromatographies failed to remove these smaller
proteins (data not shown). These results are similar to those previ-
ously reported for the puriﬁcation of heterologous expressed
PfDHFR-TS, in which it was concluded that the phenomenon is the
consequence of either protein degradation or premature termina-
tion of protein translation as evidenced from protein N-terminal se-
quencing results [22]. Although the smaller fragments may be from
any region of PoDHFR-TS, as these fragments were co-puriﬁed by
MTX-afﬁnity chromatography, they were assumed to contain the
DHFR domain. Further experiments to express PoDHFR-TS contain-
ing C-terminus tagged with either single or double hexa-histidine
sequence to facilitate puriﬁcation of the full-length PoDHFR-TSFig. 3. Coomassie blue-stained SDS-PAGE and X-ray ﬁlm exposed to [3H] FdUMP labeling
of recombinant PoDHFR-TS. Lane M, molecular weight markers; (1) uninduced cells
carrying pET17b; (2) induced cells carrying pET17b; (3) uninduced cells carrying
PoDHFR-TS gene; (4) induced cell carrying PoDHFR-TS gene; (5) insoluble fraction of (4);
(6) soluble fraction of (4); (7) puriﬁed PoDHFR-TS after MTX-afﬁnity chromatography;
(8–10) puriﬁed PoDHFR-TS, PvDHFR and TcDHFR-TS; (11–13) autoradiographs of (8–10)
following [3H] FdUMP labeling.from the truncated fragments were equally fruitless (data not
shown). The speciﬁc activities of the DHFR domain measured in
the crude extracts derived from the expression of these latter
constructs were signiﬁcantly lower than that from pET17bPoDHFR-
TS (data not shown), suggesting interference of DHFR activity by
the presence of C-terminal histidine tags.
To determine the identities of 74, 35, and 32 kDa proteins, these
bands were separately subjected to tryptic digestion and the tryptic
peptides were analyzed by LC-MS/MS. The MS/MS spectra of these
fragments were searched against an in-house created Plasmodium
database using BioworkTM 3.3 software (Thermo Scientiﬁc, USA).
The tryptic peptides of these three samples corresponded to
PoDHFR-TS with the best score among Plasmodium DHFR-TS. The
amino acid sequences of tryptic fragments of all three samples corre-
sponded well to the in silico digested peptides in DHFR, JR, and TS
domains (Fig. 1B).
To conﬁrm the presence of PoDHFR-TS, Edman N-terminal
sequence analysis was conducted. After methionine deblocking, the
ﬁrst 6 amino acid sequence obtained from 74 kDa protein was
ASMEEV, perfectly matching the N-terminus of the recombinant
PoDHFR-TS, which has an extra AS N-terminal sequence derived
from cloning into Nhe I site of pET17b. Thus, the 74 kDa protein is
the bona-ﬁde full-length PoDHFR-TS, based on mass, MS and N-
terminal sequencing data.
However, N-terminal sequencing of the 32- and 35-kDa bands did
not produce unequivocal sequencing results, but indicated the presence
of two polypeptides with N-terminal sequences ASMEEV (amino acids
1–4) and MKNVED (amino acids 337–342) present in the 32 kDa
band, and ASMEEV and MYFSFN (amino acids 323–328) in the 35 kDa
band. These polypeptide fragments are presumably due to a
chymotrypsin-like proteolytic activity [27].
TS activity in the expressed PoDHFR-TS was determined by taking
the advantage of the ability of FdUMP, a TS suicide inhibitor, to form a
covalent adduct with TS. Autoradiography revealed that [3H] FdUMP
labeled 32, 35 and 74 kDa bands (Fig. 3), in line with the data from
LC-MS/MS and N-terminal sequencing.
It can be concluded that the bifunctional PoDHFR-TS had been
obtained and had co-puriﬁed with truncated fragments containing
both DHFR and TS domains. These results also suggest the existence
of tight interactions between these domains. Mutations in the proteo-
lytic cleavage region may prevent the production of such fragments
during protein expression, with the caveat that the mutant protein
does not affect enzyme activity.
3.5. Effect of pH on DHFR and TS activities
The relationship between steady state catalytic constant and pH
for DHFR and TS demonstrated that the PoDHFR domain of the
bifunctional PoDHFR-TS was active in both the acid and neutralFig. 4. Effect of pH on DHFR (ﬁlled circles) and TS (open diamonds) activities of P. ovale.
The catalytic constants were determined for reactions performed over pH range of
4–9.5. Each data point is the average value from three experiments.
Table 3
Kinetic parameters of puriﬁed PoDHFR-TS in comparison with PfDHFR-TS and PvDHFR-TS.
Plasmodium
enzyme
DHFR activity TS activity DHFR inhibition
Km [H2folate] (μM) Km [NADPH] (μM) kcat (s−1) Km [CH2H4folate] (μM) Km [dUMP] (μM) kcat (s−1) Ki [PYR] (nM) Ki [CYC] (nM)
PoDHFR-TS 2.42±0.25 3.71±0.51 8.5±0.6 5.92±0.77 1.44±0.16 0.50±0.07 0.67±0.08 0.96±0.15
PfDHFR-TS 1.0±0.1a 4.2±0.2a 80a 2.12±0.26b 1.66±0.14b 1.13b 0.2±0.02c 0.3±0.00c
PvDHFR-TS 1.6±0.1 1.1±0.2 21.2 2.77±0.71d 3.72±0.67d 1.20d 0.21±0.03e 0.31±0.04
a–e; data from [28], [16], [30], [31], and [26], respectively.
331S. Tirakarn et al. / Parasitology International 61 (2012) 324–332ranges but the activity decreased at higher pH (Fig. 4). The optimum
pH could not be determined owing to the instability of H2folate at
pHb4. Although Plasmodium DHFRs are conserved in sequence, the
pH proﬁle obtained for PoDHFR is different from those of PfDHFR
and PvDHFR, which exhibit maximum activity around pH 7 [24,28].
However, a number of vertebrate DHFRs have higher activity in acidic
pH [29], similar to our observation for PoDHFR. On the other hand, TS
activity was similar at pH 7–9.3.6. DHFR and TS kinetic properties
Steady state kinetic parameters for PoDHFR-TS as well as the
inhibition constants for antifolates (PYR and CYC) were determined
and are summarized in Table 3. The apparent Km values for NADPH
and H2folate are similar to those of other Plasmodium DHFRs. It is
worth noting that the DHFR domain of P. ovale enzyme is the least
catalytically active, as its kcat is 9 and 2.5 folds lower than that of
the wild-type PfDHFR and PvDHFR respectively. The TS domain of
PoDHFR-TS also has half of the activity of that of other Plasmodium
species.
Standard kinetics double reciprocal plots revealed that PYR and
CYC inhibited H2folate binding to PoDHFR domain in a competitive
fashion (Fig. 5). The antimalarial antifolates, PYR and CYC, inhibited
PoDHFR at nanomolar concentrations (Table 3), similar to other
wild-type Plasmodium enzymes. Thus, P. ovale would appear to beFig. 5. Double reciprocal plots of inhibition of DHFR domain of PoDHFR-TS by (A) PYR
(0–31.25 nM) and (B) CYC (0–31.25 nM). Assays were performed in the presence of
NADPH (100 μM) and H2folate (2.5–12.5 μM). The ﬁnal concentrations of inhibitors
are indicated on each line.sensitive to antifolates, but constant monitoring of resistance in the
ﬁeld is clearly warranted.
In summary, this study reports the cloning, sequencing and heter-
ologous expression of podhfr-ts. Biochemical characterization of the
puriﬁed recombinant bifunctional PoDHFR-TS showed that it was
similar in kinetic properties with other wild-type Plasmodium species,
but with anomaly pH activity proﬁle, and that the DHFR domain was
sensitive to the antifolates, PYR and CYC. Due to the availability of
podhfr-ts, this paves theway for further structure–function relationship
studies and drug susceptibility test of site-directed mutant enzymes,
towards the goal of rational drug design directed against P. ovale.
Supplementary materials related to this article can be found
online at doi:10.1016/j.parint.2011.12.004.
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